Загрузка...
Care of the cancer survivor: metabolic syndrome following hormone-modifying therapy
Emerging evidence implicates metabolic syndrome as a long-term cancer risk factor but also suggests that certain cancer therapies may increase patients’ risk of developing metabolic syndrome secondary to cancer therapy. In particular, breast cancer and prostate cancer are driven in part by sex hormo...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2010
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2821047/ https://ncbi.nlm.nih.gov/pubmed/20102997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjmed.2009.06.022 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|